Effective nanoantibodies as promising therapeutics for treating sepsis
Ended Project Grant Awarded Last action
- Award ID
- R43GM128549
- Recipient
-
Allele Biotechnology And Pharmaceuticals, Inc. UEI VL99GKFNM1G3
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,001
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $225,001 |
Quick answers
Who received award R43GM128549?
R43GM128549 was awarded to Allele Biotechnology And Pharmaceuticals, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on September 1, 2018.
How much is award R43GM128549 worth?
$225,001 has been obligated on R43GM128549.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award